Abivax (ABVX) Interest & Investment Income (2024 - 2026)
Abivax's (ABVX) quarterly Interest & Investment Income came in at $14.9 million in Q1 2026, up 815.0% year-on-year from $1.6 million in Q1 2025, and up 167.23% quarter-over-quarter from $5.6 million in Q4 2025.
Abivax (ABVX) Interest & Investment Income (2024 - 2026) Analysis & Trends
Abivax's Interest & Investment Income history runs 3 years deep, the most recent figure standing at $14.9 million for Q1 2026.
- On a quarterly basis, Interest & Investment Income rose 815.0% year-over-year to $14.9 million in Q1 2026; TTM through Mar 2026 was $48.3 million, a 262.41% increase from a year earlier, with the FY2025 full-year figure at $32.1 million, up 115.73% from the prior year.
- Interest & Investment Income rose to $14.9 million in Q1 2026 per ABVX's latest filing, from $5.6 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $23.9 million in Q3 2025 and bottomed at $1.6 million in Q1 2025.
- The 3-year median for Interest & Investment Income is $4.0 million (2024), against an average of $7.6 million.
- Across the five-year window, Interest & Investment Income slumped 75.08% in 2025 and soared 815.0% in 2026, its largest moves.
- Year by year, Interest & Investment Income stood at $4.0 million in 2024, then surged by 38.27% to $5.6 million in 2025, then soared by 167.23% to $14.9 million in 2026.
- Per Business Quant, the three latest ABVX Interest & Investment Income figures stand at $14.9 million (Q1 2026), $5.6 million (Q4 2025), and $23.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | Abivax | 9.98 Bn | 9.98 Bn | - | 14.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.94 Mn |
| Dec 31, 2025 | 5.59 Mn |
| Sep 30, 2025 | 23.85 Mn |
| Jun 30, 2025 | 3.96 Mn |
| Mar 31, 2025 | 1.63 Mn |
| Dec 31, 2024 | 4.04 Mn |
| Sep 30, 2024 | 3.77 Mn |
| Jun 30, 2024 | 3.89 Mn |
| Mar 31, 2024 | 6.55 Mn |